Cecilia Jones

This profile gathers the share dealings of Cecilia Jones across 2 companies, led by Agios Pharmaceuticals, Inc. and LogicBio Therapeutics, Inc. Over a trading history stretching from 11 January 2022 to 2 April 2026, the count stands at 32 filings.

Sales make up the whole of the open-market record (15 sales, €792k). Outside the open market, there are 1 share grant and 16 option exercises. Since January 2026: no purchases and 6 sales on the market.

The latest filing, published on 6 April 2026, reports an open-market sale of €94k in Agios Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.